Home > Balance Sheet > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Contingent Liabilities

    Back to Balance Sheet
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Contingent Liabilities ₹65 Cr₹89 Cr₹92 Cr₹72 Cr₹61 Cr

What is the latest Contingent Liabilities ratio of NATH BIOGENES (INDIA) ?

The latest Contingent Liabilities ratio of NATH BIOGENES (INDIA) is ₹65 Cr based on Mar2026 Consolidated results.
Year Contingent Liabilities
Mar2026₹65 Cr
Mar2025₹89 Cr
Mar2024₹92 Cr
Mar2023₹72 Cr
Mar2022₹61 Cr

How is Contingent Liabilities of NATH BIOGENES (INDIA) Trending?

Years Contingent Liabilities % Change
Mar2026 ₹65 Cr
-27.09
Mar2025 ₹89 Cr
-3.34
Mar2024 ₹92 Cr
28.60
Mar2023 ₹72 Cr
18.58
Mar2022 ₹61 Cr -

Compare Contingent Liabilities of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹265.5 Cr -6.7% -11.6% -17.9% Stock Analytics
KAVERI SEED COMPANY ₹3,679.2 Cr -11.3% -5.9% -33.4% Stock Analytics
VENKYS (INDIA) ₹2,262.9 Cr -2.8% -2.5% 8.2% Stock Analytics
AVT NATURAL PRODUCTS ₹1,338.7 Cr -5.1% -0.8% 26.7% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹892.0 Cr -3.4% -3.7% NA Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹505.5 Cr -4% 9% -11.3% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-6.7%

-11.6%

-17.9%

SENSEX

-2.3%

-6.6%

-12%


You may also like the below Video Courses